apomorphine has been researched along with Depression in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (39.13) | 18.7374 |
| 1990's | 6 (13.04) | 18.2507 |
| 2000's | 8 (17.39) | 29.6817 |
| 2010's | 14 (30.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heffner, TG; Jaen, JC; Meltzer, LT; Pugsley, TA; Wise, LD | 1 |
| Chen, G; Chen, J; Chen, Y; Dai, Y; Jiang, H; Yang, B; Yu, W; Zang, F; Zhu, L | 1 |
| Brito, BM; Gobira, PH; Joca, SRL; Sartim, AG | 1 |
| Chen, L; Guo, Y; Han, LN; Li, LB; Liu, J; Sun, YN; Wang, Y; Zhang, L; Zhang, QJ; Zhang, YM | 1 |
| Arai, Y; Hisamitsu, T; Nakagawasai, O; Nakajima, T; Nemoto, W; Takahashi, K; Tan-No, K | 1 |
| Chen, L; Du, CX; Liu, J; Lv, SX; Sun, YN; Wang, T; Wang, Y; Zhang, J; Zhang, L; Zhang, QJ | 1 |
| Nakagawasai, O; Niijima, F; Onogi, H; Sato, A; Tadano, T; Tan-No, K | 1 |
| Barish, PA; Du, X; Li, G; Li, S; Ogle, WO; Pan, J; Vernon, MM; Wang, Z; Xu, Y; You, W; Zhang, X | 1 |
| Alttoa, A; Harro, J; Kanarik, M; Kõiv, K; Matrov, D; Panksepp, J; Sharp, T | 1 |
| Iezhitsa, IN; Kharitonova, MV; Kravchenko, MS; Spasov, AA | 1 |
| Cabrera, R; Casas, S; Escudero, C; García, S; Nanfaro, F; Yunes, R | 1 |
| Schnitzler, A; Südmeyer, M; Wojtecki, L | 1 |
| Andel, M; Brunerova, L; Horacek, J; Koprivova, H; Potockova, J; Rehula, M | 1 |
| Eitan, R; Goelman, G; Gordon, N; Sourani, D | 1 |
| Kulisevsky, J; Martí, MJ | 1 |
| GUENSBERGER, E; HORKOVIC KOVAC, G; TESAROVA, O | 1 |
| Antonini, A; Basile, G; Di Rosa, AE; Di Rosa, E; Epifanio, A; La Spina, P; Marconi, R; Martino, G; Morgante, L; Nicita-Mauro, V; Spina, E; Stocchi, F | 1 |
| Costentin, J; do Rego, JC; Ferraz, A; Heckler, AP; Kuze Rates, SM; Viana, A; von Poser, G | 1 |
| Ho, YJ; Hsu, CC; Hsu, WY; Lei, YP; Tseng, T; Wang, CF; Wang, WF | 1 |
| Barone, P; Bonavita, V; De Michele, G; Di Maio, L; Longo, K; Marconi, S; Vitale, C | 1 |
| An, L; Li, YF; Liu, XM; Yu, NJ; Yuan, L; Zhang, YZ; Zhao, N | 1 |
| Kos, T; Nowak, G; Popik, P; Sowa-Kućma, M | 1 |
| Eriksson, E; Modigh, K | 1 |
| Dall'Olio, R; Gandolfi, O; Montanaro, N; Vaccheri, A | 1 |
| Costain, DW; Cowen, PJ; Gelder, MG; Grahame-Smith, DG | 1 |
| Grahame-Smith, DG | 1 |
| Foti, D; Giammona, G; Nicoletti, F; Patti, F; Rampello, L; Sortino, MA; Tigano, G | 1 |
| Balldin, J; Edén, S; Granérus, AK; Modigh, K; Wålinder, J | 1 |
| Alpert, C; Belmaker, RH; Bersudsky, Y; Kofman, O; Vinnitsky, I | 1 |
| Bailey, PE; Crocq, MA; Duval, F; Macher, JP; Mokrani, MC | 1 |
| Dettling, M; Dufeu, P; Gräf, K; Heinz, A; Kuhn, S; Kürten, I; Rommelspacher, H; Schmidt, LG | 1 |
| Bonsall, RW; Emery, MS; Weiss, JM; West, CH | 1 |
| Watson, S; Young, A | 1 |
| Gobert, A; Lejeune, F; Millan, MJ | 1 |
| Modigh, K | 1 |
| Carlsson, C; Gullberg, B; Johansson, PR | 1 |
| Brunswick, D; Frazer, A; Maany, I; Mendels, J | 1 |
| Davis, JM; Garver, DL; Hengeveld, C; Pandey, GN | 1 |
| Bunney, WE | 1 |
| De la Vega, CE; Lal, S | 1 |
| Colin, JN; Lacomblez, L; Martin, P; Massol, J; Puech, AJ | 1 |
| Ansseau, M | 1 |
| Muscat, R; Towell, A; Willner, P | 1 |
| Benes, V; Benesová, O | 1 |
| Haskovec, L; König, J; Rysánek, K | 1 |
| Tesarová, O | 1 |
4 review(s) available for apomorphine and Depression
| Article | Year |
|---|---|
[Current treatment strategies for Parkinson's disease].
Topics: Aged; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Apomorphine; Critical Care; Deep Brain Stimulation; Dementia; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Europe; Female; Humans; Infusion Pumps, Implantable; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Tremor | 2011 |
[Candidate patient for treatment with continuous apomorphine infusion].
Topics: Aged; Antiparkinson Agents; Apomorphine; Clinical Trials as Topic; Cognition Disorders; Contraindications; Depression; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Hallucinations; Humans; Infusions, Intravenous; Middle Aged; Parkinson Disease; Patient Selection; Psychoses, Substance-Induced; Psychotic Disorders | 2012 |
Depression, alpha 2-receptors and sex hormones: neuroendocrine studies in rat.
Topics: Animals; Antidepressive Agents; Apomorphine; Carbidopa; Castration; Clonidine; Depression; Dihydrotestosterone; Fenclonine; Gonadal Steroid Hormones; Growth Hormone; Humans; Male; Pituitary Gland, Anterior; Rats; Receptors, Adrenergic, alpha; Reserpine; Testosterone | 1984 |
[Biological markers of depression].
Topics: Antidepressive Agents; Apomorphine; Clonidine; Contingent Negative Variation; Depression; Dexamethasone; Diagnosis, Differential; Female; Growth Hormone; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Pregnancy; Saliva; Sleep, REM | 1986 |
6 trial(s) available for apomorphine and Depression
| Article | Year |
|---|---|
Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: a follow-up of two years.
Topics: Antiemetics; Apomorphine; Brain; Cognition Disorders; Depression; Domperidone; Dopamine Agonists; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Severity of Illness Index; Single-Blind Method; Surveys and Questionnaires | 2004 |
Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial.
Topics: Adult; Antiparkinson Agents; Apomorphine; Cross-Over Studies; Depression; Double-Blind Method; Female; Humans; Huntington Disease; Infusions, Intravenous; Male; Middle Aged; Mood Disorders; Movement; Movement Disorders; Pilot Projects; Psychiatric Status Rating Scales | 2007 |
Electroconvulsive therapy and the brain: evidence for increased dopamine-mediated responses.
Topics: Amitriptyline; Antidepressive Agents; Apomorphine; Brain; Depression; Dopamine; Electroconvulsive Therapy; Female; Growth Hormone; Humans; Male | 1982 |
Multihormonal responses to apomorphine in mental illness.
Topics: Adrenocorticotropic Hormone; Adult; Apomorphine; Depression; Dopamine Agonists; Female; Growth Hormone; Humans; Hydrocortisone; Injections, Subcutaneous; Male; Mental Disorders; Middle Aged; Prolactin; Receptors, Dopamine; Schizophrenia; Thyrotropin | 1995 |
A double-blind cross-over study: apomorphine/placebo in chronic alcoholics.
Topics: Adult; Alcoholism; Apomorphine; Clinical Trials as Topic; Depression; Double-Blind Method; Humans; Middle Aged; Placebos; Sleep | 1977 |
Apomorphine and psychopathology.
Topics: Alcoholism; Antidepressive Agents; Apomorphine; Bipolar Disorder; Clinical Trials as Topic; Depression; Humans; Libido; Male; Middle Aged; Penis; Placebos; Psychiatric Status Rating Scales; Psychomotor Disorders; Psychoses, Substance-Induced; Schizophrenia | 1975 |
36 other study(ies) available for apomorphine and Depression
| Article | Year |
|---|---|
Dopamine autoreceptor agonists as potential antipsychotics. 2. (Aminoalkoxy)-4H-1-benzopyran-4-ones.
Topics: Animals; Antipsychotic Agents; Benzopyrans; Binding, Competitive; Brain; Corpus Striatum; Depression; Dopamine; Dopamine Agents; Haloperidol; Indicators and Reagents; Mice; Molecular Structure; Motor Activity; Neurons; Rats; Receptors, Dopamine; Structure-Activity Relationship; Synapses | 1991 |
Changes in Male Rat Sexual Behavior and Brain Activity Revealed by Functional Magnetic Resonance Imaging in Response to Chronic Mild Stress.
Topics: Animals; Apomorphine; Brain; Depression; Disease Models, Animal; Erectile Dysfunction; Female; Magnetic Resonance Imaging; Male; Penile Erection; Rats; Rats, Wistar; Sexual Behavior | 2018 |
Attenuation of glutamatergic and nitrergic system contributes to the antidepressant-like effect induced by capsazepine in the forced swimming test.
Topics: 2-Amino-5-phosphonovalerate; Animals; Antidepressive Agents; Apomorphine; Arginine; Capsaicin; Cyclic GMP; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Enzyme Inhibitors; Exploratory Behavior; Glutamic Acid; Male; Microinjections; Nitric Oxide; Nitroprusside; Rats; Receptors, N-Methyl-D-Aspartate; Statistics, Nonparametric; Swimming | 2019 |
Activation of serotonin(2C) receptors in the lateral habenular nucleus increases the expression of depression-related behaviors in the hemiparkinsonian rat.
Topics: Action Potentials; Adrenergic Agents; Animals; Apomorphine; Depression; Disease Models, Animal; Dopamine Agonists; Exploratory Behavior; Food Preferences; Functional Laterality; Habenula; Male; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Serotonin Agents; Substantia Nigra; Sucrose; Swimming | 2015 |
Alterations in behavioral responses to dopamine agonists in olfactory bulbectomized mice: relationship to changes in the striatal dopaminergic system.
Topics: Animals; Apomorphine; Corpus Striatum; Depression; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopaminergic Neurons; Imipramine; Male; Mice; Motor Activity; Nucleus Accumbens; Olfactory Bulb; Receptors, Dopamine D2; Smell; Tyrosine 3-Monooxygenase | 2016 |
Involvement of lateral habenula α1 subunit-containing GABA
Topics: Action Potentials; Animals; Apomorphine; Depression; Dopamine Agonists; GABA Antagonists; GABA-A Receptor Agonists; Habenula; Male; Muscimol; Neural Inhibition; Neurons; Oxidopamine; Parkinsonian Disorders; Picrotoxin; Prefrontal Cortex; Rats, Sprague-Dawley; Receptors, GABA-A; Serotonin | 2017 |
Effect of non-selective dopaminergic receptor agonist on disrupted maternal behavior in olfactory bulbectomized mice.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Apomorphine; Depression; Disease Models, Animal; Dopamine Agonists; Exploratory Behavior; Female; Food Preferences; Maternal Behavior; Mice; Olfactory Bulb; Sexual Behavior, Animal; Sucrose; Sweetening Agents | 2010 |
Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system.
Topics: Animals; Antidepressive Agents; Antioxidants; Apomorphine; Behavior, Animal; Brain Chemistry; Depression; Dose-Response Relationship, Drug; Fenclonine; Hindlimb Suspension; Hypothermia; Male; Mice; Mice, Inbred ICR; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Norepinephrine; Resveratrol; Serotonin; Stereotyped Behavior; Stilbenes; Swimming | 2010 |
Brain responses to chronic social defeat stress: effects on regional oxidative metabolism as a function of a hedonic trait, and gene expression in susceptible and resilient rats.
Topics: Adrenal Glands; Animals; Apomorphine; Behavior, Animal; Body Weight; Brain; Depression; Dopamine Agonists; Energy Metabolism; Gene Expression; Gene Expression Profiling; Microarray Analysis; Rats; Rats, Wistar; Resilience, Psychological; Stress, Psychological; Sucrose; Sweetening Agents; Swimming | 2011 |
Effect of magnesium chloride on psychomotor activity, emotional status, and acute behavioural responses to clonidine, d-amphetamine, arecoline, nicotine, apomorphine, and L-5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Anxiety; Apomorphine; Arecoline; Clonidine; Depression; Diet; Dietary Supplements; Emotions; Magnesium; Magnesium Chloride; Magnesium Deficiency; Male; Neurotransmitter Agents; Nicotine; Psychomotor Performance; Rats; Rats, Wistar; Stereotyped Behavior; Vitamin B 6 | 2011 |
Progesterone prevents depression-like behavior in a model of Parkinson's disease induced by 6-hydroxydopamine in male rats.
Topics: Amphetamine; Animals; Antidepressive Agents; Apomorphine; Cues; Depression; Dopamine Agonists; Male; Memory; Oxidopamine; Parkinson Disease, Secondary; Progesterone; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Stereotyped Behavior; Swimming; Sympatholytics | 2011 |
Sublingual apomorphine as a neuroendocrine probe.
Topics: Administration, Sublingual; Adult; Anxiety; Apomorphine; Biomarkers; Depression; Dopamine Agonists; Growth Hormone; Humans; Male; Neurosecretory Systems; Prolactin; Self Report; Time Factors | 2012 |
The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Apomorphine; Depression; Dopamine; Habenula; Hippocampus; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Parkinsonian Disorders; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Serotonin; Swimming; Thalamus | 2012 |
[METHODOLOGICAL MEANS FOR VERIFICATION OF MODEL DEPRESSIONS].
Topics: Apomorphine; Depression; Depressive Disorder; Humans | 1963 |
The antidepressant-like effect of Hypericum caprifoliatum Cham & Schlecht (Guttiferae) on forced swimming test results from an inhibition of neuronal monoamine uptake.
Topics: Animals; Antidepressive Agents; Apomorphine; Binding, Competitive; Depression; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Hypericum; Hypothermia; In Vitro Techniques; Male; Mice; Motor Activity; Neurotransmitter Uptake Inhibitors; Norepinephrine; Plant Extracts; Rats; Rats, Wistar; Serotonin; Swimming; Synaptosomes | 2005 |
Effects of apomorphine on the expression of learned helplessness behavior.
Topics: Adaptation, Psychological; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Depression; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Electric Stimulation; Helplessness, Learned; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 2007 |
Role for serotonin in the antidepressant-like effect of a flavonoid extract of Xiaobuxin-Tang.
Topics: Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Feeding Behavior; Fenclonine; Flavonoids; Humans; Hypothermia; Male; Mice; Mice, Inbred ICR; Motor Activity; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Serotonin; Stress, Physiological; Yohimbine | 2008 |
Lack of persistent effects of ketamine in rodent models of depression.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Apomorphine; Cerebral Cortex; Depression; Desipramine; Dopamine Agonists; Drug Tolerance; Excitatory Amino Acid Antagonists; Exploratory Behavior; Hindlimb Suspension; Ketamine; Male; Mice; Mice, Inbred C57BL; Motor Activity; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Adrenergic, beta; Swimming | 2008 |
Neuroleptic versus antidepressant activity of sulpiride isomers in the rat.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Apomorphine; Behavior, Animal; Depression; Exploratory Behavior; Haloperidol; Humans; Male; Motor Activity; Rats; Rats, Inbred Strains; Stereoisomerism; Sulpiride | 1982 |
The neuropharmacological effects of electroconvulsive shock and their relationship to the therapeutic effect of electroconvulsive therapy in depression.
Topics: Anesthesia, General; Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Brain; Corticosterone; Depression; Dopamine; Electroconvulsive Therapy; gamma-Aminobutyric Acid; Growth Hormone; Humans; Mice; Motor Activity; Norepinephrine; Rats; Seizures; Serotonin | 1984 |
[Role of the amygdala in the sedation induced by low doses of apomorphine].
Topics: Amygdala; Animals; Apomorphine; Depression; Humans; Imipramine; Motor Activity; Rats; Rats, Inbred Strains | 1983 |
Electroconvulsive therapy and receptor sensitivity.
Topics: Animals; Apomorphine; Catecholamines; Clonidine; Depression; Electroconvulsive Therapy; Growth Hormone; Humans; Male; Mice; Motor Activity; Rats; Receptors, Adrenergic; Receptors, Dopamine | 1981 |
The effect of peripheral inositol injection on rat motor activity models of depression.
Topics: Amphetamine; Analysis of Variance; Animals; Apomorphine; Depression; Disease Models, Animal; Drug Synergism; Glucose; Inositol; Lithium; Male; Motor Activity; Pilocarpine; Rats; Rats, Sprague-Dawley; Seizures; Stereotyped Behavior | 1993 |
Psychopathological and behavioral correlates of dopaminergic sensitivity in alcohol-dependent patients.
Topics: Adult; Alcoholism; Anxiety; Apomorphine; Depression; Exploratory Behavior; Female; Human Growth Hormone; Humans; Male; Middle Aged; Receptors, Dopamine; Treatment Outcome | 1996 |
Rats selectively bred for high and low swim-test activity show differential responses to dopaminergic drugs.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Depression; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Rats; Rats, Sprague-Dawley; Species Specificity; Stereotyped Behavior; Swimming | 1999 |
Dopaminergic sensitivity and prediction of antidepressant response.
Topics: Antidepressive Agents, Second-Generation; Apomorphine; Depression; Dopamine Agonists; Human Growth Hormone; Humans; Paroxetine; Predictive Value of Tests | 2000 |
The selective neurokinin (NK)(1) antagonist, GR205,171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electrophysiological study.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Animals; Antiemetics; Apomorphine; Depression; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Extracellular Space; Isomerism; Male; Microdialysis; Neural Pathways; Neurokinin-1 Receptor Antagonists; Piperidines; Prefrontal Cortex; Presynaptic Terminals; Rats; Rats, Wistar; Receptors, Neurokinin-1; Serotonin Receptor Agonists; Synaptic Transmission; Tetrazoles; Up-Regulation; Ventral Tegmental Area | 2002 |
Electroconvulsive shock and postsynaptic catecholamine effects: increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS.
Topics: Animals; Apomorphine; Brain; Catecholamines; Clonidine; Depression; Electroshock; Humans; Male; Mice; Motor Activity; Receptors, Adrenergic; Receptors, Cholinergic; Receptors, Neurotransmitter; Reserpine; Time Factors | 1975 |
A study of growth hormone release in depression.
Topics: Adult; Apomorphine; Bipolar Disorder; Depression; Growth Hormone; Humans; Levodopa; Male; Middle Aged | 1979 |
Growth hormone response and central aminergic systems in affective diseases [proceedins].
Topics: Affective Symptoms; Apomorphine; Biogenic Amines; Bipolar Disorder; Depression; Growth Hormone; Humans; Hypoglycemia; Methoxyhydroxyphenylglycol | 1977 |
Nonstriatal dopaminergic neurons: Section XI. Dopaminergic neurons and mental diseases: Introduction: dopaminergic neurons and mental diseases.
Topics: Apomorphine; Bromocriptine; Catecholamines; Depression; Dopamine; Homovanillic Acid; Humans; Levodopa; Mental Disorders; Neurons; Schizophrenia | 1977 |
Antidepressant profile of bupropion and three metabolites in mice.
Topics: Animals; Antidepressive Agents; Apomorphine; Body Temperature; Bupropion; Depression; Male; Mice; Motor Activity; Pimozide; Prazosin; Propiophenones; Propranolol; Reserpine; Yohimbine | 1990 |
Changes in dopamine autoreceptor sensitivity in an animal model of depression.
Topics: Animals; Apomorphine; Body Weight; Depression; Desipramine; Disease Models, Animal; Eating; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stress, Physiological | 1988 |
Experimental study on the mechanism of depressogenic action of apomorphine and reserpine.
Topics: Acetylcholine; Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Depression; Diencephalon; Dopamine; Dose-Response Relationship, Drug; Humans; Male; Norepinephrine; Rats; Reserpine; Serotonin; Telencephalon | 1972 |
The effect of reserpine and nortriptyline on the excretion of 17-hydroxysteroids.
Topics: Animals; Apomorphine; Behavior, Animal; Depression; Drug Synergism; Grooming; Humans; Imipramine; Liver; Male; Motor Activity; Rats; Reserpine; Tryptophan Oxygenase | 1971 |
[Mechanims of thymoleptic drug action studied on the model of apomorphine depression].
Topics: Apomorphine; Depression; Humans; Models, Chemical; Psychological Tests; Tranquilizing Agents | 1968 |